Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 31, 2016
Sudden-Onset Sensorineural Hearing Loss after Immunization: A Case-Centered AnalysisRoger Baxter, Ned Lewis, Pamela Bohrer, et al.
Vaccine|February 7, 2017
Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49yearsRoger Baxter, Abigail Eaton, John Hansen, et al.
Vaccine|July 12, 2016
Risk of underlying chronic medical conditions for invasive pneumococcal disease in adultsRoger Baxter, Arnold Yee, Laurie Aukes, et al.
Vaccine|May 17, 2017
Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccineNicola P Klein, Joan Bartlett, Bruce Fireman, et al.
BMJ (Clinical Research Ed.)|November 8, 2023
Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health recordsNicola P Klein, Joan Bartlett, Bruce Fireman, et al.
Vaccine|July 15, 2019
Long-term effectiveness of zoster vaccine live for postherpetic neuralgia preventionNicola P Klein, Joan Bartlett, Bruce Fireman, et al.
Pediatrics|April 13, 2011
Evaluation of immunization rates and safety among children with inborn errors of metabolismNicola P Klein, Laurie Aukes, Janelle Lee, et al.
Vaccine|February 12, 2013
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of ageSeth L Toback, Christopher S Ambrose, Abigail Eaton, et al.
Vaccine|March 20, 2012
A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of ageRoger Baxter, Seth L Toback, Frangiscos Sifakis, et al.
Vaccine|March 6, 2012
A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of ageRoger Baxter, Seth L Toback, Frangiscos Sifakis, et al.
Pageof 2